Replies to post #173536 on Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

Cellceutix is evaluating Brilacidin, under Fast Track designation, in a Phase 2 clinical trial as an oral rinse to attenuate Oral Mucositis in patients with Head and Neck Cancer who have received chemoradiation.

Fast Track - next post